Acetylcholinesterase (AChE) and beta-secretase (BACE-1) are two attractive targets in the discovery of novel substances that could control multiple aspects of Alzheimer’s disease (AD). Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.